Persistence makes perfect: the benefits of IL-2 in adoptive immunotherapy.
Rizzuto
G A
GA
Swim Across America Laboratory of Tumor Immunology, Memorial Sloan-Kettering Cancer Center, New York 10021, USA.
Wolchok
J D
JD
D000208:Acute Disease; D000818:Animals; D018106:CD28 Antigens / Q000276:immunology*; D017252:CD3 Complex / Q000276:immunology*; D045744:Cell Line, Tumor; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D007951:Leukemia, Myeloid / Q000276:immunology / Q000628:therapy; D008213:Lymphocyte Activation / Q000187:drug effects*; D051379:Mice; D008822:Mice, Transgenic; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation
D018106:CD28 Antigens; D017252:CD3 Complex; D007376:Interleukin-2